327 related articles for article (PubMed ID: 29209160)
1. Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.
Chen J; Huang XF; Shao R; Chen C; Deng C
Front Neurosci; 2017; 11():643. PubMed ID: 29209160
[TBL] [Abstract][Full Text] [Related]
2. Effects of antipsychotic medications on appetite, weight, and insulin resistance.
Deng C
Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886
[TBL] [Abstract][Full Text] [Related]
3. Severe parkinsonism under treatment with antipsychotic drugs.
Druschky K; Bleich S; Grohmann R; Engel RR; Toto S; Neyazi A; Däubl B; Stübner S
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):35-47. PubMed ID: 31444566
[TBL] [Abstract][Full Text] [Related]
4. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure.
Chestnykh DA; Amato D; Kornhuber J; Müller CP
Behav Brain Res; 2021 Apr; 403():113144. PubMed ID: 33515642
[TBL] [Abstract][Full Text] [Related]
6. Proteomic study revealed antipsychotics-induced nuclear protein regulations in B35 cells are similar to the regulations in C6 cells and rat cortex.
Li T; Lee M; Tsai F; Chen Y; Lin Y; Chen M
BMC Pharmacol Toxicol; 2018 Mar; 19(1):9. PubMed ID: 29514709
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric drugs impact mitochondrial function in brain and other tissues.
Chan ST; McCarthy MJ; Vawter MP
Schizophr Res; 2020 Mar; 217():136-147. PubMed ID: 31744750
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
[TBL] [Abstract][Full Text] [Related]
9. Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era.
Basu A; Meltzer HY
Schizophr Res; 2006 Sep; 86(1-3):99-109. PubMed ID: 16753284
[TBL] [Abstract][Full Text] [Related]
10. The impact of antiplatelet drugs on trauma outcomes.
Ferraris VA; Bernard AC; Hyde B
J Trauma Acute Care Surg; 2012 Aug; 73(2):492-7. PubMed ID: 23019676
[TBL] [Abstract][Full Text] [Related]
11. Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task.
Prus AJ; Philibin SD; Pehrson AL; Porter JH
Behav Pharmacol; 2005 Nov; 16(7):511-20. PubMed ID: 16170228
[TBL] [Abstract][Full Text] [Related]
12. The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management.
Baptista T; De Mendoza S; Beaulieu S; Bermúdez A; Martinez M
Metab Syndr Relat Disord; 2004; 2(4):290-307. PubMed ID: 18370698
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics and glucose homeostasis.
Bergman RN; Ader M
J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs.
Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
Eur J Clin Pharmacol; 2001 Jul; 57(4):327-31. PubMed ID: 11549212
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic mechanisms as targets for existing and novel antipsychotics.
Meltzer HY
Handb Exp Pharmacol; 2012; (212):87-124. PubMed ID: 23129329
[TBL] [Abstract][Full Text] [Related]
16. Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.
Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
Clin Ther; 2013 Oct; 35(10):1513-1525.e1. PubMed ID: 24139423
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Effects of Antipsychotics on Appetite Control.
Mukherjee S; Skrede S; Milbank E; Andriantsitohaina R; López M; Fernø J
Front Nutr; 2021; 8():815456. PubMed ID: 35047549
[TBL] [Abstract][Full Text] [Related]
18. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
19. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.
Baptista T; Zárate J; Joober R; Colasante C; Beaulieu S; Páez X; Hernández L
Curr Drug Targets; 2004 Apr; 5(3):279-99. PubMed ID: 15058313
[TBL] [Abstract][Full Text] [Related]
20. The role of serotonin receptors in the action of atypical antipsychotic drugs.
Meltzer HY; Massey BW
Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
